Optimization and Validation of Dosage Regimen for Ceftiofur against <i>Pasteurella multocida</i> in Swine by Physiological Based Pharmacokinetic–Pharmacodynamic Model

Model informed drug development is a valuable tool for drug development and clinical application due to its ability to integrate variability and uncertainty of data. This study aimed to determine an optimal dosage of ceftiofur against <i>P. multocida</i> by ex vivo pharmacokinetic/pharma...

Full description

Bibliographic Details
Main Authors: Kun Mi, Shanju Pu, Yixuan Hou, Lei Sun, Kaixiang Zhou, Wenjin Ma, Xiangyue Xu, Meixia Huo, Zhenli Liu, Changqing Xie, Wei Qu, Lingli Huang
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/7/3722
_version_ 1797439038179770368
author Kun Mi
Shanju Pu
Yixuan Hou
Lei Sun
Kaixiang Zhou
Wenjin Ma
Xiangyue Xu
Meixia Huo
Zhenli Liu
Changqing Xie
Wei Qu
Lingli Huang
author_facet Kun Mi
Shanju Pu
Yixuan Hou
Lei Sun
Kaixiang Zhou
Wenjin Ma
Xiangyue Xu
Meixia Huo
Zhenli Liu
Changqing Xie
Wei Qu
Lingli Huang
author_sort Kun Mi
collection DOAJ
description Model informed drug development is a valuable tool for drug development and clinical application due to its ability to integrate variability and uncertainty of data. This study aimed to determine an optimal dosage of ceftiofur against <i>P. multocida</i> by ex vivo pharmacokinetic/pharmacodynamic (PK/PD) model and validate the dosage regimens by Physiological based Pharmacokinetic-Pharmacodynamic (PBPK/PD) model. The pharmacokinetic profiles of ceftiofur both in plasma and bronchoalveolar lavage fluid (BALF) are determined. PD performance of ceftiofur against <i>P. multocida</i> was investigated. By establishing PK/PD model, PK/PD parameters and doses were determined. PBPK model and PBPK/PD model were developed to validate the dosage efficacy. The PK/PD parameters, AUC<sub>0–24 h</sub>/MIC, for bacteriostatic action, bactericidal action and elimination were determined as 44.02, 89.40, and 119.90 h and the corresponding dosages were determined as 0.22, 0.46, and 0.64 mg/kg, respectively. AUC<sub>24 h</sub>/MIC and AUC <sub>72 h</sub>/MIC are simulated by PBPK model, compared with the PK/PD parameters, the therapeutic effect can reach probability of target attainment (PTA) of 90%. The time-courses of bacterial growth were predicted by the PBPK/PD model, which indicated the dosage of 0.46 mg/kg body weight could inhibit the bacterial growth and perform good bactericidal effect.
first_indexed 2024-03-09T11:47:02Z
format Article
id doaj.art-fb78cf076e9f4e5eb17e0954fa3d8043
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T11:47:02Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-fb78cf076e9f4e5eb17e0954fa3d80432023-11-30T23:21:07ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-03-01237372210.3390/ijms23073722Optimization and Validation of Dosage Regimen for Ceftiofur against <i>Pasteurella multocida</i> in Swine by Physiological Based Pharmacokinetic–Pharmacodynamic ModelKun Mi0Shanju Pu1Yixuan Hou2Lei Sun3Kaixiang Zhou4Wenjin Ma5Xiangyue Xu6Meixia Huo7Zhenli Liu8Changqing Xie9Wei Qu10Lingli Huang11National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, ChinaMAO Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan 430070, ChinaNational Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, ChinaNational Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, ChinaMAO Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan 430070, ChinaNational Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, ChinaMAO Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan 430070, ChinaNational Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, ChinaNational Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, ChinaNational Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, ChinaNational Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, ChinaNational Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, ChinaModel informed drug development is a valuable tool for drug development and clinical application due to its ability to integrate variability and uncertainty of data. This study aimed to determine an optimal dosage of ceftiofur against <i>P. multocida</i> by ex vivo pharmacokinetic/pharmacodynamic (PK/PD) model and validate the dosage regimens by Physiological based Pharmacokinetic-Pharmacodynamic (PBPK/PD) model. The pharmacokinetic profiles of ceftiofur both in plasma and bronchoalveolar lavage fluid (BALF) are determined. PD performance of ceftiofur against <i>P. multocida</i> was investigated. By establishing PK/PD model, PK/PD parameters and doses were determined. PBPK model and PBPK/PD model were developed to validate the dosage efficacy. The PK/PD parameters, AUC<sub>0–24 h</sub>/MIC, for bacteriostatic action, bactericidal action and elimination were determined as 44.02, 89.40, and 119.90 h and the corresponding dosages were determined as 0.22, 0.46, and 0.64 mg/kg, respectively. AUC<sub>24 h</sub>/MIC and AUC <sub>72 h</sub>/MIC are simulated by PBPK model, compared with the PK/PD parameters, the therapeutic effect can reach probability of target attainment (PTA) of 90%. The time-courses of bacterial growth were predicted by the PBPK/PD model, which indicated the dosage of 0.46 mg/kg body weight could inhibit the bacterial growth and perform good bactericidal effect.https://www.mdpi.com/1422-0067/23/7/3722ceftiofur<i>Pasteurella multocida</i>PBPK/PD modeldosage regimenmathematical model
spellingShingle Kun Mi
Shanju Pu
Yixuan Hou
Lei Sun
Kaixiang Zhou
Wenjin Ma
Xiangyue Xu
Meixia Huo
Zhenli Liu
Changqing Xie
Wei Qu
Lingli Huang
Optimization and Validation of Dosage Regimen for Ceftiofur against <i>Pasteurella multocida</i> in Swine by Physiological Based Pharmacokinetic–Pharmacodynamic Model
International Journal of Molecular Sciences
ceftiofur
<i>Pasteurella multocida</i>
PBPK/PD model
dosage regimen
mathematical model
title Optimization and Validation of Dosage Regimen for Ceftiofur against <i>Pasteurella multocida</i> in Swine by Physiological Based Pharmacokinetic–Pharmacodynamic Model
title_full Optimization and Validation of Dosage Regimen for Ceftiofur against <i>Pasteurella multocida</i> in Swine by Physiological Based Pharmacokinetic–Pharmacodynamic Model
title_fullStr Optimization and Validation of Dosage Regimen for Ceftiofur against <i>Pasteurella multocida</i> in Swine by Physiological Based Pharmacokinetic–Pharmacodynamic Model
title_full_unstemmed Optimization and Validation of Dosage Regimen for Ceftiofur against <i>Pasteurella multocida</i> in Swine by Physiological Based Pharmacokinetic–Pharmacodynamic Model
title_short Optimization and Validation of Dosage Regimen for Ceftiofur against <i>Pasteurella multocida</i> in Swine by Physiological Based Pharmacokinetic–Pharmacodynamic Model
title_sort optimization and validation of dosage regimen for ceftiofur against i pasteurella multocida i in swine by physiological based pharmacokinetic pharmacodynamic model
topic ceftiofur
<i>Pasteurella multocida</i>
PBPK/PD model
dosage regimen
mathematical model
url https://www.mdpi.com/1422-0067/23/7/3722
work_keys_str_mv AT kunmi optimizationandvalidationofdosageregimenforceftiofuragainstipasteurellamultocidaiinswinebyphysiologicalbasedpharmacokineticpharmacodynamicmodel
AT shanjupu optimizationandvalidationofdosageregimenforceftiofuragainstipasteurellamultocidaiinswinebyphysiologicalbasedpharmacokineticpharmacodynamicmodel
AT yixuanhou optimizationandvalidationofdosageregimenforceftiofuragainstipasteurellamultocidaiinswinebyphysiologicalbasedpharmacokineticpharmacodynamicmodel
AT leisun optimizationandvalidationofdosageregimenforceftiofuragainstipasteurellamultocidaiinswinebyphysiologicalbasedpharmacokineticpharmacodynamicmodel
AT kaixiangzhou optimizationandvalidationofdosageregimenforceftiofuragainstipasteurellamultocidaiinswinebyphysiologicalbasedpharmacokineticpharmacodynamicmodel
AT wenjinma optimizationandvalidationofdosageregimenforceftiofuragainstipasteurellamultocidaiinswinebyphysiologicalbasedpharmacokineticpharmacodynamicmodel
AT xiangyuexu optimizationandvalidationofdosageregimenforceftiofuragainstipasteurellamultocidaiinswinebyphysiologicalbasedpharmacokineticpharmacodynamicmodel
AT meixiahuo optimizationandvalidationofdosageregimenforceftiofuragainstipasteurellamultocidaiinswinebyphysiologicalbasedpharmacokineticpharmacodynamicmodel
AT zhenliliu optimizationandvalidationofdosageregimenforceftiofuragainstipasteurellamultocidaiinswinebyphysiologicalbasedpharmacokineticpharmacodynamicmodel
AT changqingxie optimizationandvalidationofdosageregimenforceftiofuragainstipasteurellamultocidaiinswinebyphysiologicalbasedpharmacokineticpharmacodynamicmodel
AT weiqu optimizationandvalidationofdosageregimenforceftiofuragainstipasteurellamultocidaiinswinebyphysiologicalbasedpharmacokineticpharmacodynamicmodel
AT linglihuang optimizationandvalidationofdosageregimenforceftiofuragainstipasteurellamultocidaiinswinebyphysiologicalbasedpharmacokineticpharmacodynamicmodel